AllianceBernstein (PRCT) discloses 147,327 shares; 0.3% stake reported

Rhea-AI Filing Summary

AllianceBernstein L.P. amended its Schedule 13G to report 147,327 shares of PROCEPT BioRobotics Corp Common Stock held in discretionary client accounts. The filing states AllianceBernstein has sole voting power for 146,027 shares and sole dispositive power for 147,327 shares, representing 0.3% of the class. The amendment is signed on 05/15/2026.

Insights

Institutional Ownership Analyst

Large asset manager reports a small passive stake in PROCEPT (0.3%).

AllianceBernstein discloses 147,327 shares held for discretionary client accounts, with 146,027 shares subject to sole voting power. The filing is an amended Schedule 13G/A, indicating a passive investor reporting change rather than an active strategic stake.

Cash‑flow treatment and intent beyond passive investment are not stated; subsequent filings would show any material change in ownership or voting intent.

Compliance & Reporting Specialist

Amendment clarifies beneficial ownership and voting/dispositive authorities.

The filing attributes beneficial ownership to AllianceBernstein L.P. and notes its corporate relationship to Equitable Holdings, Inc.; AllianceBernstein reports independent management and separate beneficial‑ownership reporting. The Schedule 13G/A form and the signatures comply with passive investor disclosure rules.

Materiality is limited by the 0.3% stake; any change above the 5% threshold would trigger different reporting obligations.

Key Figures

Beneficial ownership: 147,327 shares Sole voting power: 146,027 shares Percent of class: 0.3% +1 more

4 metrics

Beneficial ownership 147,327 shares reported on Schedule 13G/A

Sole voting power 146,027 shares voting authority reported in filing

Percent of class 0.3% percent of outstanding common stock

Signature date 05/15/2026 filing signed by compliance associate

Key Terms

Schedule 13G/A, beneficially owned, sole dispositive power

3 terms

Schedule 13G/A regulatory

"amended its Schedule 13G to report beneficial ownership"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

beneficially owned financial

"Amount beneficially owned: 147,327 shares acquired solely for investment"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole dispositive power regulatory

"Sole power to dispose or to direct the disposition of: 147,327"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

PROCEPT BioRobotics Corp

(Name of Issuer)

Common Stock

(Title of Class of Securities)

74276L105

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 74276L105

1

Names of Reporting Persons

AllianceBernstein L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 146,027.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 147,327.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

147,327.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.3 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: PROCEPT BioRobotics Corp
(b)	Address of issuer's principal executive offices: 150 BAYTECH DRIVE,, SAN JOSE,, CA, 95134
Item 2.
(a)	Name of person filing: AllianceBernstein L.P. ("AllianceBernstein L.P.")
(b)	Address or principal business office or, if none, residence: 501 Commerce Street, Nashville, TN 37203 All media outlets, please contact Jennifer Will at AllianceBernstein (212-969-1157) with any questions. All other questions can be directed to Section13USFilings@alliancebernstein.com.
(c)	Citizenship: Delaware
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 74276L105
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 147,327 shares acquired solely for investment purposes on behalf of client discretionary investment advisory accounts.* *AllianceBernstein L.P. is a majority owned subsidiary of Equitable Holdings, Inc. ("EQH"). AllianceBernstein operates under independent management and makes independent decisions from EQH and its respective subsidiaries, and EQH calculates and reports beneficial ownership separately from AllianceBernstein pursuant to guidance provided by the Securities and Exchange Commission in Release Number 34-39538 (January 12, 1998).
(b)	Percent of class: 0.3 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 146,027
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 147,327
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

AllianceBernstein L.P.

Signature:	Marcus Edwards
Name/Title:	AVP/ Senior Compliance Associate
Date:	05/15/2026

FAQ

What stake does AllianceBernstein hold in PROCEPT (PRCT)?

AllianceBernstein reports beneficial ownership of 147,327 shares of PROCEPT Common Stock, representing 0.3% of the class. The shares are held in discretionary client accounts and reported on an amended Schedule 13G/A.

How many shares does AllianceBernstein have voting control over for PRCT?

The filing states AllianceBernstein has sole voting power for 146,027 shares. Shared voting power is reported as 0, indicating exclusive voting authority over that portion of the reported holdings.

Does AllianceBernstein own these shares directly or on behalf of clients?

AllianceBernstein holds the reported 147,327 shares for discretionary investment advisory client accounts. The filing attributes beneficial ownership to AllianceBernstein as investment manager, not as direct corporate ownership.

Why does the filing mention Equitable Holdings, Inc.?

The amendment notes AllianceBernstein is a majority‑owned subsidiary of Equitable Holdings, Inc., and clarifies that AllianceBernstein operates under independent management and reports beneficial ownership separately from Equitable Holdings.

When was the Schedule 13G/A amendment signed?

The Schedule 13G/A amendment is signed by Marcus Edwards, AVP/Senior Compliance Associate, on 05/15/2026, certifying the reported ownership and powers described in the filing.